Clinical Trial Update: Endpoint Determination Study Protocol [NA]

View source ↗

Summary

This document outlines a study protocol for determining endpoints in an Irritable Bowel Syndrome trial sponsored by Biomerica.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Biomerica | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED